Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2023
Programm
Personen
Suche
EN
Alle Personen
Andreas Argyriou
Sortiert nach Typ
Datum
Vortrag
ePoster
P009
OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine
ePoster
P010
Predictors of response to fremanezumab in migraine patients with at least three previous preventive failures: post-hoc analysis of a prospective, multicenter, real-world Greek registry
ePoster
P011
Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real-world data from a Greek registry
ePoster
P012
Effects of fremanezumab on psychiatric comorbidities in difficult-to-treat patients with chronic migraine: post-hoc analysis of a prospective, multicenter, real-world Greek registry
Weitere Beteiligungen
ePoster
P009
OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine
ePoster
P010
Predictors of response to fremanezumab in migraine patients with at least three previous preventive failures: post-hoc analysis of a prospective, multicenter, real-world Greek registry
ePoster
P011
Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real-world data from a Greek registry
ePoster
P012
Effects of fremanezumab on psychiatric comorbidities in difficult-to-treat patients with chronic migraine: post-hoc analysis of a prospective, multicenter, real-world Greek registry
ePoster
P197
The significance of the circadian time of administration on the effectiveness and tolerability of OnabotulinumtoxinA for chronic migraine prophylaxis
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz